---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-306757"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2025-12-03T23:59:59+00:00"
generated_at: "2026-05-16T15:28:30.636618+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
confidence: "medium"
source: SEC EDGAR
---

# Semnur Pharmaceuticals files updated securities description reflecting charter and bylaws amendments

## Summary
- Updates description of common stock and warrants per amendments to certificate of incorporation and bylaws since 2024 year-end.
- Securities continue to trade on OTCQB under symbols SMNR and SMNRW; no change in trading status.
- No material financial or operational events disclosed; filing is administrative in nature.

## SEC filing metadata
- accession: 0001193125-25-306757
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2025-12-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000119312525306757/0001193125-25-306757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000119312525306757/d42925d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-306757
- JSON: https://secwatch.observer/filing/0001193125-25-306757.json
- Plain text: https://secwatch.observer/filing/0001193125-25-306757.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.